Borage seed oil
Borage seed oil has one of the highest amounts of γ-linolenic acid (GLA) of seed oils — higher than blackcurrant seed oil or evening primrose oil, to which it is considered similar. GLA typically comprises about 24% of the oil.
GLA is converted to dihomo-γ-linolenic acid (DGLA), a precursor to a variety of the 1-series prostaglandins and the 3-series leukotrienes. It inhibits leukotriene synthesis to provide therapy in rheumatologic illness. Borage seed oil may therefore have anti-inflammatory and anti-thrombotic effects and it has been studied for its potential to treat inflammatory disorders, arthritis, atopic eczema, and respiratory inflammation.
In herbal medicine, borage seed oil has been used for skin disorders such as eczema, seborrheic dermatitis, and neurodermatitis; it has also been used for rheumatoid arthritis, stress, premenstrual syndrome, diabetes, attention deficit-hyperactivity disorder (ADHD), acute respiratory distress syndrome (ARDS), alcoholism, pain and swelling (inflammation), and for preventing heart disease and stroke. There is insufficient scientific evidence to determine the effectiveness of borage for a majority of these uses.
Borage oil may contain the pyrrolizidine alkaloid amabiline, which is hepatotoxic leading to a risk of liver damage. Patients should use borage oil certified free of toxic unsaturated pyrrolizidine alkaloids (UPAs). Consumption of 1-2 g of borage seed oil daily can result in an intake of toxic UPAs approaching 10 ug. The German Federal Health Agency specifies consumption to be limited to 1 ug of UPA daily.
Seizures have been reported as a complication of ingestion of borage oil in doses of 1,500 to 3,000 mg daily, although a mixed review of borage oil's effect on seizure thresholds indicates that borage oil quality varies. A specific extraction process may offer purified products with 50%+ GLA content.
Borage seed oil might prolong bleeding time, increase the risk of bruising and bleeding, and increase the risk of bleeding during and after surgery.
- Borage at Sloan-Kettering website
- "Borage". WebMD. Retrieved 19 February 2014.
- Henz, BM; Jablonska, S; Van De Kerkhof, PC; Stingl, G; Blaszczyk, M; Vandervalk, PG; Veenhuizen, R; Muggli, R; Raederstorff, D (1999). "Double-blind, multicentre analysis of the efficacy of borage oil in patients with atopic eczema". The British journal of dermatology. 140 (4): 685–8. PMID 10233322. doi:10.1046/j.1365-2133.1999.02771.x.
- Takwale, A; Tan, E; Agarwal, S; Barclay, G; Ahmed, I; Hotchkiss, K; Thompson, JR; Chapman, T; Berth-Jones, J (2003). "Efficacy and tolerability of borage oil in adults and children with atopic eczema: Randomised, double blind, placebo controlled, parallel group trial". BMJ (Clinical research ed.). 327 (7428): 1385. PMC . PMID 14670885. doi:10.1136/bmj.327.7428.1385.
- Bamford, JT; Ray, S; Musekiwa, A; van Gool, C; Humphreys, R; Ernst, E (Apr 30, 2013). "Oral evening primrose oil and borage oil for eczema.". The Cochrane database of systematic reviews. 4: CD004416. PMID 23633319. doi:10.1002/14651858.CD004416.pub2.
- Dodson, Craig D.; Stermitz, Frank R. (1986). "Pyrrolizidine alkaloids from borage (Borago officinalis) seeds and flowers". Journal of Natural Products. 49 (4): 727–728. doi:10.1021/np50046a045.
- Parvais, O.; Vander Stricht, B.; Vanhaelen-Fastre, R.; Vanhaelen, M. (1994). "TLC detection of pyrrolizidine alkaloids in oil extracted from the seeds of Borago officinalis". Journal of Planar Chromatography--Modern TLC. 7 (1): 80–82.
- Wretensjoe, Inger; Karlberg, Bo. (2003). "Pyrrolizidine alkaloid content in crude and processed borage oil from different processing stages". Journal of the American Oil Chemists' Society. 80 (10): 963–970. doi:10.1007/s11746-003-0804-z.
- Kast, RE (2001). "Borage oil reduction of rheumatoid arthritis activity may be mediated by increased cAMP that suppresses tumor necrosis factor-alpha". International immunopharmacology. 1 (12): 2197–9. PMID 11710548. doi:10.1016/s1567-5769(01)00146-1.
- Al-Khamees, W. A. A.; Schwartz, M. D.; Alrashdi, S.; Algren, A. D.; Morgan, B. W. (2011). "Status Epilepticus Associated with Borage Oil Ingestion". Journal of Medical Toxicology. 7 (2): 154–157. PMC . PMID 21387119. doi:10.1007/s13181-011-0135-9.
- Spinella, M. (2001). "Herbal Medicines and Epilepsy: The Potential for Benefit and Adverse Effects". Epilepsy & Behavior. 2 (6): 524–532. PMID 12609386. doi:10.1006/ebeh.2001.0281.
|This vegetable oil-related article is a stub. You can help Wikipedia by expanding it.|